Department published revised Pharmaceutical Benefits Scheme Minimum Stockholding Guidelines

Page last updated: 14 August 2025

The Department has published an updated version of the Pharmaceutical Benefits Scheme Minimum Stockholding Guidelines (the Guidelines). Updates have been made based on recommendations made in the 12-month review of the Minimum Stockholding Requirements (MSR). Key updates include: New section Section 6.3 - Assessing applications based on short shelf-life. New Section 4.7 - The department’s approach to designated brands that are undergoing trade name changes (‘rebranding’). New section 4.1 - demand variation. Revised Section 8.1 - Approach to Compliance. Revised Section 8.3 - Additional matters added that the Minister may consider when an Responsible Person is non-compliant e.g. stock in transit, loss of significant supply contract.